These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6971326)

  • 1. Variations in some of the body fluid hormone levels currently used for endocrine monitoring during the third trimester of pregnancy.
    Pedretti E; Capitanio GL; Casadio M; Lanera P; Conte N
    J Perinat Med; 1981; 9(1):40-7. PubMed ID: 6971326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential determination of serum human placental lactogen, estriol, and estetrol for assessment of fetal morbidity.
    Kundu N; Carmody PJ; Didolkar SM; Petersen LP
    Obstet Gynecol; 1978 Nov; 52(5):513-20. PubMed ID: 724167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum concentrations of SP1, HLP and estriol in last trimester of normal pregnancy: circadian variations and influence of labour (author's transl)].
    Tatra G; Stopfer H; Scheiber V
    Z Geburtshilfe Perinatol; 1976 Jun; 180(3):215-9. PubMed ID: 960962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualized cosinor assessment of circadian hormonal variation in third trimester human pregnancy.
    Meis PJ; Buster JE; Kundu N; Magyar D; Marshall JR; Halberg F
    Chronobiologia; 1983; 10(1):1-11. PubMed ID: 6221911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What are the most suitable fetoplacental tests in the monitoring of the third trimester of pregnancy?
    Grella PV; Enrichi M; Tambuscio G; Ronsisvalle O; Murari G; Resta P; Nardelli GB; Sormani-Zodo F; Barazzuol G; Marchesoni D
    Clin Exp Obstet Gynecol; 1982; 9(2):69-73. PubMed ID: 6186418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental protein and hormone measurements in twin pregnancy.
    Westergaard JG; Teisner B; Hau J; Grudzinskas JG
    Br J Obstet Gynaecol; 1985 Jan; 92(1):72-6. PubMed ID: 2578286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pregnancy-specific beta 1-glycoprotein, HCG alpha subunit, alpha fetoproteins and HPL in fetal hypotrophy].
    Ruseva R; Marinov B; Milkov V; Milanov S
    Akush Ginekol (Sofiia); 1984; 23(4):315-20. PubMed ID: 6207743
    [No Abstract]   [Full Text] [Related]  

  • 8. Human placental lactogen, pregnancy-specific beta-1-glycoprotein and alpha-fetoprotein in serum in threatened abortion.
    Hertz JB; Schultz-Larsen P
    Int J Gynaecol Obstet; 1983 Apr; 21(2):111-7. PubMed ID: 6193015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of plasma placental proteins and estriol in the detection of intrauterine growth retardation.
    Nisbet AD; Horne CH; Jandial V; Bremner RD; Cruickshank N; Sutcliffe RG
    Eur J Obstet Gynecol Reprod Biol; 1982 Sep; 13(6):333-42. PubMed ID: 6182039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monitoring of HPL, estriol and estetrol in high-risk pregnancy].
    Gherzi R; Pastore M; Labate D
    Minerva Ginecol; 1981 Oct; 33(10):911-6. PubMed ID: 7312213
    [No Abstract]   [Full Text] [Related]  

  • 11. [The laboratory in monitoring high-risk pregnancy].
    Radillo L; Cociancich G; D'Atri A; Ghionni A; Mangiarotti M
    Quad Sclavo Diagn; 1981 Jun; 17(2):164-71. PubMed ID: 6973774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies.
    Bersinger NA; Ødegård RA
    Acta Obstet Gynecol Scand; 2004 Jan; 83(1):37-45. PubMed ID: 14678084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of serum human placental lactogen and Schwangerschaftsprotein 1 to determine gestation in an ante-natal population.
    Thomson MA; Duncan RO; Cunningham P
    Hum Reprod; 1988 May; 3(4):463-5. PubMed ID: 3292569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of measurement of pregnancy-specific proteins in twin pregnancies.
    Jandial V; Horne CH; Glover RG; Nisbet AD; Campbell DM; MacGillivray I
    Acta Genet Med Gemellol (Roma); 1979; 28(4):319-25. PubMed ID: 318010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of growth retardation by biochemical methods.
    Klopper A
    Clin Obstet Gynaecol; 1984 Aug; 11(2):437-55. PubMed ID: 6332704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in placental lactogen, beta 1-chorionic gonadotropin, and unconjugated and total estriol levels in the late course of normal human pregnancy.
    Furuhashi N; Tachibana Y; Kono H; Shinkawa O; Takahashi T; Suzuki M
    Tohoku J Exp Med; 1984 May; 143(1):47-51. PubMed ID: 6205470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of bromocriptine on the endocrine profile during pregnancy].
    Kubota T; Yaoi Y; Suzuki A; Nishi N; Saito M; Kumasaka T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Oct; 34(10):1675-83. PubMed ID: 7175275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Daily variations in pregnancy hormones].
    Oestreicher M; Oestreicher S; Schmidt-Gollwitzer M
    Z Geburtshilfe Perinatol; 1985; 189(3):140-3. PubMed ID: 3876655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of the determination of free estriol (E3) and of placental lactogen (HPL) in the monitoring of high-risk pregnancy].
    Ghionni A; Briani G; Pasini L
    Minerva Ginecol; 1979; 31(1-2):13-8. PubMed ID: 471308
    [No Abstract]   [Full Text] [Related]  

  • 20. Weight percentile at birth. II. Prediction by endocrinological and sonographic measurements.
    Gerhard I; Vollmar B; Runnebaum B; Klinga K; Haller U; Kubli F
    Eur J Obstet Gynecol Reprod Biol; 1987 Dec; 26(4):313-28. PubMed ID: 3319732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.